Role of chemotherapy in the management of epithelial ovarian cancer.

about

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

P2860

Q39493576-69517018-5E50-43F9-ACBD-1CEB44F3B0A5

P2860

Role of chemotherapy in the management of epithelial ovarian cancer.

Item

http://www.wikidata.org/entity/Q36066178

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Role of chemotherapy in the management of epithelial ovarian cancer.

@ast

Role of chemotherapy in the management of epithelial ovarian cancer.

@en

type

Item

label

Role of chemotherapy in the management of epithelial ovarian cancer.

@ast

Role of chemotherapy in the management of epithelial ovarian cancer.

@en

prefLabel

Role of chemotherapy in the management of epithelial ovarian cancer.

@ast

Role of chemotherapy in the management of epithelial ovarian cancer.

@en

P1476

Role of chemotherapy in the management of epithelial ovarian cancer.

@en

P2093

Azmat H Sadozye

http://www.w3.org/2001/XMLSchema#string

Nicholas S Reed

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer.

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.

Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes.

Weekly topotecan in the management of ovarian cancer.

Primary gastrointestinal cancers presenting as gynecologic malignancies.

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.

P304

139-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.5.1.139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15757446

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

Role of chemotherapy in the management of epithelial ovarian cancer.

about

P2860

P2860

Role of chemotherapy in the management of epithelial ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921